Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 2005 Aug 15;96(4):512-4
Date
08/16/2005Pubmed ID
16098302DOI
10.1016/j.amjcard.2005.04.011Scopus ID
2-s2.0-23644451310 (requires institutional sign-in at Scopus site) 83 CitationsAbstract
We report on the incidence of adverse cardiac events in 350 patients who underwent noncardiac surgery within 2 months of successful balloon angioplasty (BA) at our institution between 1988 and 2001. Three patients died perioperatively (n = 1) or had myocardial infarction (n = 2) (0.9%, 95% confidence interval [CI] 0.2% to 2.5%), which is a lower incidence than that reported for patients undergoing noncardiac surgery after stenting (3.9% to 32%). One patient died, and 2 had a nonfatal myocardial infarction. All 3 (1.6%, 95% CI 0.3% to 4.6%) were among the 188 patients who underwent surgery within 2 weeks of BA. Repeat target vessel revascularization was performed in 10 patients (2.9%, 95% CI 1.4% to 5.2%): in 3 (1.6%, 95% CI 0.3% to 4.6%) of 188 patients who underwent surgery within 2 weeks of BA and in 7 (5.1%, 95% CI 2.1% to 10.2%) of 138 patients who underwent surgery within 3 to 7 weeks of BA. Therefore, in patients in whom percutaneous coronary revascularization is required before noncardiac surgery, BA appears to be safe, especially in patients who need to undergo surgery early after percutaneous coronary intervention.
Author List
Brilakis ES, Orford JL, Fasseas P, Wilson SH, Melby S, Lennon RJ, Berger PBAuthor
Panayotis Fasseas MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedAngioplasty, Balloon, Coronary
Coronary Angiography
Digestive System Surgical Procedures
Endosonography
Female
Follow-Up Studies
Humans
Male
Myocardial Ischemia
Orthopedic Procedures
Perioperative Care
Retrospective Studies
Survival Rate
Time Factors
Treatment Outcome
Urogenital Surgical Procedures
